Ranloc Med HEARTBURN REFLUX 20 mg 14 tablets
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
(edit with the Customer Reassurance module)
Ranloc Med 20 mg 14 tablets
Manufacturer:
RANBAXY (POLAND) SP. Z O.O.
Indications
Short-term treatment of symptoms of gastroesophageal reflux disease (such as heartburn, acid belching) in adults.
Composition
1 gastro-resistant tablet contains 20 mg of pantoprazole.
Dosage
The recommended dose is 20 mg of pantoprazole (1 tablet) per day.
You may need to take the tablets for another 2 to 3 days to get relief from your symptoms. After complete resolution of symptoms, treatment should be discontinued. Without consulting a doctor, treatment should not last longer than 4 weeks.
Enter-resistant tablets containing pantoprazole 20 mg should not be chewed or crushed, they should be taken before a meal, swallowed whole and with liquid
Contraindications
Hypersensitivity to the active substance or to any of the excipients.
Simultaneous administration with atazanavir.
Package
14 tablets .
Responsible entity
RANBAXY (POLAND) SP. Z O.O.
Before use, read the leaflet, which contains indications, contraindications, data on side effects and dosage, as well as information on the use of the medicinal product, or consult a doctor or pharmacist, because each drug If used incorrectly, it threatens your life or health.
feedback Report comment